ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

IOBT IO Biotech Inc

1.50
0.04 (2.74%)
Last Updated: 09:44:17
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
IO Biotech Inc IOBT NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.04 2.74% 1.50 09:44:17
Open Price Low Price High Price Close Price Prev Close
1.50 1.50 1.50 1.46
more quote information »

Recent News

Date Time Source Heading
4/25/20248:52IHNWFeaturedCannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA
4/24/202416:30GLOBEIO Biotech Announces Abstract Accepted for Presentation at..
4/15/202408:30GLOBEIO Biotech Expands Senior Leadership Team to Progress..
4/09/202412:00GLOBEIO Biotech Presents New Data at AACR 2024 Further Supporting..
4/05/202408:30GLOBEIO Biotech Appoints Faiçal Miyara, Ph.D., as Chief Business..
3/11/202416:56EDGAR2Form S-8 - Securities to be offered to employees in employee..
3/06/202416:11GLOBEIO Biotech Announces Acceptance of Abstract to be Presented..
3/05/202417:17EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
3/05/202416:46EDGAR2Form 8-K - Current report
3/05/202416:40GLOBEIO Biotech Announces 2023 Fourth-Quarter and Year-End..
2/26/202416:05GLOBEIO Biotech to Present at 44th Annual Cowen Health Care..
1/08/202408:11EDGAR2Form 8-K - Current report
12/21/202308:30GLOBEIO Biotech Announces First Patient Dosed in Phase 2..
11/24/202317:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/13/202316:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/13/202308:12GLOBEIO Biotech Announces 2023 Third Quarter Results
11/13/202308:10EDGAR2Form 8-K - Current report
11/13/202308:00GLOBEIO Biotech Appoints Helen Collins, MD, to its Board of..
11/10/202308:00GLOBEIO Biotech Completes Enrollment of 380 Patients in Pivotal..
11/08/202316:30GLOBEIO Biotech Announces Participation in Upcoming Investor..
11/01/202308:30GLOBEIO Biotech Presents Three Posters at the Society for..
10/23/202301:00GLOBEEncouraging Preliminary Data from a Phase 2 Trial Evaluating..
10/03/202316:30GLOBEIO Biotech Announces Three Poster Presentations at the..
9/12/202316:06EDGAR2Form 424B2 - Prospectus [Rule 424(b)(2)]
9/12/202308:05GLOBEIO Biotech Announces New Data Related to its IO102-IO103..
9/11/202300:15EDGAR2Form EFFECT - Notice of Effectiveness
9/07/202310:36EDGAR2Form SC 13G - Statement of acquisition of beneficial..
9/06/202308:35GLOBEIO Biotech Announces Participation in Upcoming Investor..
8/30/202316:16EDGAR2Form S-3 - Registration statement under Securities Act of..
8/15/202318:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/15/202317:57EDGAR2Form 3 - Initial statement of beneficial ownership of..
8/11/202321:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/11/202308:41EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/11/202308:31EDGAR2Form 8-K - Current report
8/11/202308:30GLOBEIO Biotech Announces 2023 Second Quarter Results
8/11/202308:05GLOBEIO Biotech Appoints Heidi Hunter to its Board of Directors
8/09/202320:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/09/202320:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/08/202308:05GLOBEIO Biotech Announces Abstract Accepted for Poster..
8/07/202308:31EDGAR2Form 8-K - Current report
8/07/202308:30GLOBEIO Biotech, Inc. Announces $75 Million Private Placement..
7/28/202308:05GLOBEIO Biotech Announces First Patient Dosed in..
7/25/202316:05GLOBEIO Biotech Announces Abstract Accepted for Mini Oral..
7/19/202316:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
7/19/202316:10EDGAR2Form 3 - Initial statement of beneficial ownership of..
7/18/202316:05EDGAR2Form 8-K - Current report
7/18/202316:05GLOBEIO Biotech Strengthens Executive Management and US Presence..
6/14/202308:00GLOBEIO Biotech Announces Achievement of Significant Phase 3..
6/01/202308:30GLOBEIO Biotech Appoints Christine Richter, Ph.D., MBA, as Senior..

Your Recent History

Delayed Upgrade Clock